Relief and Volatility Ahead for U.S. Stocks

Relief and Volatility Ahead for U.S. Stocks

Our CIO and Chief U.S. Equity Strategist Mike Wilson unpacks why stocks are likely to stay resilient despite uncertainties related to Fed rates, government shutdown and tariffs.

Read more insights from Morgan Stanley.


----- Transcript -----


Welcome to Thoughts on the Market. I'm Mike Wilson, Morgan Stanley’s CIO and Chief U.S. Equity Strategist. Today on the podcast, I’ll be discussing recent concerns for equities and how that may be changing.

It's Monday, November 10th at 11:30am in New York.

So, let’s get after it.

We’re right in the middle of earnings season. Under the surface, there may appear to be high dispersion. But we’re actually seeing positive developments for a broadening in growth. Specifically, the median stock is seeing its best earnings growth in four years. And the S&P 500 revenue beat rate is running 2 times its historical average. These are clear signs that the earning recovery is broadening and that pricing power is firming to offset tariffs.

We’re also watching out for other predictors of soft spots. And over the past week, the seasonal weakness in earnings revision breath appears to be over. For reference, this measure troughed at 6 percent on October 21st, and is now at 11 percent. The improvement is being led by Software, Transports, Energy, Autos and Healthcare.

Despite this improvement in earnings revisions, the overall market traded heavy last week on the back of two other risks. The first risk relates to the Fed's less dovish bias at October's FOMC meeting. The Fed suggested they are not on a preset course to cut rates again in December. So, it’s not a coincidence the U.S. equity market topped on the day of this meeting. Meanwhile investors are also keeping an eye on the growth data during the third quarter. If it’s stronger than anticipated, it could mean there’s less dovish action from the Fed than the market expects or needs for high prices.

I have been highlighting a less dovish Fed as a risk for stocks. But it’s important to point out that the labor market is also showing increasing signs of weakness. Part of this is directly related to the government shutdown. But the private labor data clearly illustrates a jobs market that's slowing beyond just government jobs. This is creating some tension in the markets – that the Fed will be late to cut rates, which increases the risk the recovery since April falls flat.

In my view, labor market weakness coupled with the administration's desire to "run it hot" means that ultimately the Fed is likely to deliver more dovish policy than the market currently expects. But, without official jobs data confirming this trend, the Fed is moving slower than the equity market may like.

The other risk the market has been focused on is the government shutdown itself. And there appears to be two main channels through which these variables are affecting stock prices. The first is tighter liquidity as reflected in the recent decline in bank reserves. The government shutdown has resulted in fewer disbursements to government employees and other programs. Once the government shutdown ends which appears imminent, these payments will resume, which translates into an easing of liquidity.

The second impact of the shutdown is weaker consumer spending due to a large number of workers furloughed and benefits, like SNAP, halted. As a result, Consumer Discretionary company earnings revisions have rolled over. The good news is that the shutdown may be coming to an end and alleviate these market concerns.

Finally, tariffs are facing an upcoming Supreme Court decision. There were questions last week on how affected stocks were reacting to this development. Overall, we saw fairly muted relative price reactions from the stocks that would be most affected. We think this relates to a couple of variables. First, the Trump administration could leverage a number of other authorities to replace the existing tariffs. Second, even in a scenario where the Supreme Court overturns tariffs, refunds are likely to take a significant amount of time, potentially well into 2026.

So what does all of this all mean? Weak earnings seasonality is coming to an end along with the government shutdown. Both of these factors should lead to some relief in what have been softer equity markets more recently. But we expect volatility to persist until the Fed fully commits to the run it hot strategy of the administration.

Thanks for tuning in; I hope you found it informative and useful. Let us know what you think by leaving us a review. And if you find Thoughts on the Market worthwhile, tell a friend or colleague to try it out!

Jaksot(1567)

What the New Tax Bill Means for Cross-Border Portfolios

What the New Tax Bill Means for Cross-Border Portfolios

Our Global Head of Fixed Income Research and Public Policy Strategy Michael Zezas reads the fine print of U.S. tax legislation to understand how it might affect foreign companies operating in the U.S....

11 Kesä 20253min

How China Is Rewriting the AI Code

How China Is Rewriting the AI Code

Our Head of Asia Technology Research Shawn Kim discusses China's distinctly different approach to AI development and its investment implications.Read more insights from Morgan Stanley.----- Transcript...

10 Kesä 20253min

U.S. Financials Conference: Three Key Themes to Watch

U.S. Financials Conference: Three Key Themes to Watch

Our analysts Betsy Graseck, Manan Gosalia and Ryan Kenny discuss the major discussions they expect to highlight Morgan Stanley’s upcoming U.S. Financials conference.Read more insights from Morgan Stan...

9 Kesä 202510min

Standing by Our Outlook

Standing by Our Outlook

Morgan Stanley’s midyear outlook defied the conventional view in a number of ways. Our analysts Serena Tang and Vishy Tirupattur push back on the pushback to their conclusions, explaining the thought ...

6 Kesä 20259min

5 Reasons the Obesity Drug Market Remains Strong

5 Reasons the Obesity Drug Market Remains Strong

The global market for obesity drugs is expanding. Our U.S. Pharma and Biotech Analyst Terrence Flynn discusses what’s driving the next stage of global growth for GLP-1 medicines.Read more insights fro...

5 Kesä 20253min

Midyear U.S. Credit Outlook: Why Investors Should Be Selective

Midyear U.S. Credit Outlook: Why Investors Should Be Selective

Our analysts Andrew Sheets and Vishwas Patkar take stock of the U.S. credit market, noting which segments are on firm footing going into a period of slower growth.Read more insights from Morgan Stanle...

4 Kesä 20257min

U.S. Shoppers Take Stock

U.S. Shoppers Take Stock

Our Thematics and U.S. Economics analysts Michelle Weaver and Arunima Sinha discuss how American consumers are planning to spend as they consider tariffs, inflation and potential new tax policies. Rea...

3 Kesä 20259min

Why Equity Markets May Be Stronger Than You Think

Why Equity Markets May Be Stronger Than You Think

Our CIO and Chief U.S. Equity Strategist Mike Wilson explains how his outlook on earnings and valuations give him a constructive view on U.S. equities for the next 12 months.Read more insights from Mo...

2 Kesä 20254min

Suosittua kategoriassa Liike-elämä ja talous

sijotuskasti
mimmit-sijoittaa
psykopodiaa-podcast
rss-rahapodi
ostan-asuntoja-podcast
pomojen-suusta
rss-rahamania
rss-draivi
inderespodi
rss-seuraava-potilas
rss-sami-miettinen-neuvottelija
rss-myyntikoulu
rss-paasipodi
rahapuhetta
salkunrakentaja-podi
kasvun-kipuja
lakicast
rss-lahtijat
rss-bisnesta-bebeja
rss-asuntosalkku-kasvussa-podcast